Ignite Creation Date:
2025-12-24 @ 3:01 PM
Ignite Modification Date:
2026-01-29 @ 2:26 PM
Study NCT ID:
NCT00879359
Status:
COMPLETED
Last Update Posted:
2017-04-26
First Post:
2009-04-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trial of Vascular Endothelial Growth Factor (VEGF), Bevacizumab, in Combination With Cytotoxic Chemotherapy for Endometrial Cancer
Sponsor:
The Cleveland Clinic
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
20806
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |